These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 22934291

  • 1. Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy.
    Spyropoulos AC, Douketis JD, Gerotziafas G, Kaatz S, Ortel TL, Schulman S, Subcommittee on Control of Anticoagulation of the SSC of the ISTH.
    J Thromb Haemost; 2012 Apr; 10(4):692-4. PubMed ID: 22934291
    [No Abstract] [Full Text] [Related]

  • 2. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
    Koziński M, Obońska K, Kubica A, Navarese EP, Kubica J.
    Kardiol Pol; 2012 Apr; 70(10):1053-60. PubMed ID: 23080100
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
    Lane DA, Wood K.
    Circulation; 2015 Apr 21; 131(16):e412-5. PubMed ID: 25901074
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis.
    Skjøth F, Larsen TB, Rasmussen LH, Lip GY.
    Thromb Haemost; 2014 May 05; 111(5):981-8. PubMed ID: 24577485
    [Abstract] [Full Text] [Related]

  • 7. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.
    Gómez-Outes A, Terleira-Fernández AI, Lecumberri R, Suárez-Gea ML, Vargas-Castrillón E.
    Thromb Res; 2014 Oct 05; 134(4):774-82. PubMed ID: 25037495
    [Abstract] [Full Text] [Related]

  • 8. Direct oral anticoagulants in atrial fibrillation.
    Noll G, Noll S, Hürlimann D.
    Semin Hematol; 2014 Apr 05; 51(2):139-46. PubMed ID: 24861798
    [Abstract] [Full Text] [Related]

  • 9. Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials.
    Sardar P, Chatterjee S, Lavie CJ, Giri JS, Ghosh J, Mukherjee D, Lip GY.
    Int J Cardiol; 2015 Jan 20; 179():279-87. PubMed ID: 25464465
    [Abstract] [Full Text] [Related]

  • 10. Bleeding and antidotes in new oral anticoagulants.
    Majeed A, Schulman S.
    Best Pract Res Clin Haematol; 2013 Jun 20; 26(2):191-202. PubMed ID: 23953907
    [Abstract] [Full Text] [Related]

  • 11. [Rivaroxaban, dabigatran and apixaban: new anticoagulants in operative urology].
    John A, Michel MS.
    Urologe A; 2014 Jun 20; 53(6):893-902; quiz 903. PubMed ID: 24845012
    [Abstract] [Full Text] [Related]

  • 12. [New clinical perspectives in the management of oral direct anticoagulant agents].
    Marco P, Zamorano JL, Chana F, Llau JV.
    Med Clin (Barc); 2014 Feb 20; 142(4):171-8. PubMed ID: 23866969
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Management of direct action oral anticoagulants in the peri-operative period and invasive techniques].
    Llau JV, Ferrandis R, Castillo J, de Andrés J, Gomar C, Gómez-Luque A, Hidalgo F, Torres LM, participantes en el Foro de Consenso de la ESRA-España sobre «Fármacos que alteran la hemostasia».
    Rev Esp Anestesiol Reanim; 2012 Feb 20; 59(6):321-30. PubMed ID: 22633209
    [Abstract] [Full Text] [Related]

  • 17. New oral anticoagulants for non-valvular atrial fibrillation--safety issues.
    Barry M.
    Ir Med J; 2013 Mar 20; 106(3):69. PubMed ID: 23951972
    [No Abstract] [Full Text] [Related]

  • 18. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY, Larsen TB, Skjøth F, Rasmussen LH.
    J Am Coll Cardiol; 2012 Aug 21; 60(8):738-46. PubMed ID: 22575324
    [Abstract] [Full Text] [Related]

  • 19. [Bleeding and surgery in the treatment with new oral anticoagulants. The management can be complicated by the lack of specific antidotes].
    Dalén M, Hjemdahl P, Holmström M, Ivert T.
    Lakartidningen; 2012 Aug 21; 111(24):1064-8. PubMed ID: 25129916
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.